Section to complete information about the primary medical condition(s) or problem(s) studied and, a characteristics of the intervention(s).
Health condition(s) or Problem(s) studied:
Health condition(s) code:
Condylomata Acuminata
Warts
Papillomavirus Infections
DNA Virus Infections
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Skin Diseases, Viral
Tumor Virus Infections
Virus Diseases
Skin Diseases, Infectious
Skin Diseases
Intervention(s):
Group I. One daily intramuscular application of 10x106 UI of the product under study for 2 consecutive days. Group II. One daily intramuscular application of 5x106 UI of the product under study for 4 consecutive days. Group III. One daily intramuscular application of 3x106 UI of the product under study for 7 consecutive days. The three groups will thus receive practically the same weekly dosage of 20x106 UI.
Intervention code:
Interferon-alpha
Interferons
Injections, Intramuscular
Intervention keyword:
recombinant human alpha-2b interferon